Implantica AG (IPLTF)
OTCMKTS · Delayed Price · Currency is USD
4.660
-0.170 (-3.52%)
At close: Mar 5, 2026
Implantica AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.86 | 64.55 | 87.92 | 108.95 | 84.33 |
Short-Term Investments | 29 | - | - | - | 48.4 |
Cash & Short-Term Investments | 48.86 | 64.55 | 87.92 | 108.95 | 132.74 |
Cash Growth | -24.31% | -26.58% | -19.30% | -17.92% | 36.12% |
Accounts Receivable | 0.67 | 0.59 | 0.43 | 0.09 | 0.01 |
Other Receivables | 1.98 | 0.61 | 0.35 | 0.22 | 0.15 |
Receivables | 2.65 | 1.2 | 0.78 | 0.31 | 0.16 |
Inventory | 0.31 | 0.23 | 0.31 | 0.17 | 0.14 |
Prepaid Expenses | - | 1.04 | 0.64 | 0.64 | 0.33 |
Total Current Assets | 51.81 | 67.02 | 89.65 | 110.07 | 133.36 |
Property, Plant & Equipment | 0.42 | 0.81 | 1.15 | 1.37 | 0.32 |
Other Intangible Assets | 32.77 | 0.07 | 0.09 | 0.01 | 0.03 |
Long-Term Deferred Tax Assets | 0.9 | 0.97 | 0.99 | 0.99 | 0.98 |
Long-Term Deferred Charges | - | 35.22 | 38.07 | 35.96 | 28.44 |
Total Assets | 85.9 | 104.08 | 129.95 | 148.41 | 163.13 |
Accounts Payable | 0.03 | 1.69 | 2.11 | 1.67 | 1.81 |
Accrued Expenses | - | 1.17 | 1.24 | 1.17 | 1.01 |
Current Portion of Leases | 0.09 | 0.31 | 0.31 | 0.33 | 0.09 |
Other Current Liabilities | 2.79 | 0.14 | 0.08 | 0.08 | 0.31 |
Total Current Liabilities | 2.91 | 3.3 | 3.75 | 3.24 | 3.21 |
Long-Term Leases | 0.12 | 0.29 | 0.58 | 0.82 | - |
Pension & Post-Retirement Benefits | 0.27 | 0.33 | 0.58 | 0.27 | 0.23 |
Total Liabilities | 3.31 | 3.92 | 4.91 | 4.32 | 3.44 |
Common Stock | 129.6 | 129.35 | 129.14 | 129.14 | 129.14 |
Retained Earnings | -429.59 | -411.27 | -388.06 | -364.19 | -344.23 |
Treasury Stock | - | -0.07 | -0 | - | - |
Comprehensive Income & Other | 385.02 | 384.73 | 386.2 | 380.6 | 375.71 |
Total Common Equity | 85.03 | 102.74 | 127.27 | 145.55 | 160.62 |
Minority Interest | -2.43 | -2.58 | -2.23 | -1.47 | -0.93 |
Shareholders' Equity | 82.59 | 100.16 | 125.05 | 144.09 | 159.69 |
Total Liabilities & Equity | 85.9 | 104.08 | 129.95 | 148.41 | 163.13 |
Total Debt | 0.21 | 0.6 | 0.9 | 1.15 | 0.09 |
Net Cash (Debt) | 48.65 | 63.96 | 87.02 | 107.81 | 132.64 |
Net Cash Growth | -23.93% | -26.51% | -19.28% | -18.73% | 36.31% |
Net Cash Per Share | 0.17 | 0.23 | 0.31 | 0.38 | 0.47 |
Filing Date Shares Outstanding | 283.33 | 283.18 | 283.11 | 283.11 | 283.11 |
Total Common Shares Outstanding | 283.33 | 283.18 | 283.11 | 283.11 | 283.11 |
Working Capital | 48.9 | 63.72 | 85.91 | 106.84 | 130.15 |
Book Value Per Share | 0.30 | 0.36 | 0.45 | 0.51 | 0.57 |
Tangible Book Value | 52.26 | 102.67 | 127.18 | 145.54 | 160.59 |
Tangible Book Value Per Share | 0.18 | 0.36 | 0.45 | 0.51 | 0.57 |
Machinery | - | 0.63 | 0.59 | 0.49 | 0.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.